Biodegradable drug-eluting coronary artery stent

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Dostępny od:

Abbott Vascular Division of Abbott Medical Australia Pty Ltd

Klasa:

Class I

Wyprodukowano przez:

Abbott Vascular 3200 Lakeside Drive, Santa Clara, CA, 95054 United States Of America

Dziedzina terapeutyczna:

56304 - Biodegradable drug-eluting coronary artery stent

Wskazania:

The Absorb Bioresorbable Vascular Scaffold is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions. The treated lesion length should be less than the nominal scaffolding length (8 mm, 12 mm, 18 mm, 23 mm, 28 mm) with reference vessel diameters (RVD) ? 2.5 mm and ? 3.75 mm.

Status autoryzacji:

A

Data autoryzacji:

2017-07-06